Your browser doesn't support javascript.
loading
Correlations of disease severity outcome measures in inclusion body myositis.
Goyal, Namita A; Greenberg, Steven A; Cauchi, Jonathan; Araujo, Nadia; Li, Vivian; Wencel, Marie; Irani, Tyler; Wang, Leo H; Palma, Anton M; Villalta, S Armando; Mozaffar, Tahseen.
Afiliação
  • Goyal NA; Department of Neurology, University of California, Irvine, CA, United States. Electronic address: namitag@hs.uci.edu.
  • Greenberg SA; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
  • Cauchi J; Department of Neurology, University of California, Irvine, CA, United States.
  • Araujo N; Department of Neurology, University of California, Irvine, CA, United States.
  • Li V; Department of Neurology, University of California, Irvine, CA, United States.
  • Wencel M; Department of Neurology, University of California, Irvine, CA, United States.
  • Irani T; Department of Neurology, University of California, Irvine, CA, United States.
  • Wang LH; Department of Neurology, University of Washington Medical Center, Seattle, WA, United States.
  • Palma AM; Institute for Clinical and Translational Science, University of California, Irvine, CA, United States.
  • Villalta SA; Department of Neurology, University of California, Irvine, CA, United States; Institute for Immunology, United States; Department of Physiology and Biophysics, United States.
  • Mozaffar T; Department of Neurology, University of California, Irvine, CA, United States; Institute for Immunology, United States; Department of Pathology and Laboratory Medicine, University of California, Irvine, CA, United States.
Neuromuscul Disord ; 32(10): 800-805, 2022 10.
Article em En | MEDLINE | ID: mdl-36050251
ABSTRACT
This study aimed to evaluate the correlation between various outcome measures used to assess disease severity and progression in inclusion body myositis (IBM) clinical trials. A cross-sectional study, involving 51 IBM patients meeting the European Neuromuscular Center (ENMC) 2011 criteria for clinically defined or probable IBM, was completed at the University of California, Irvine. Clinical details, demographic data, and functional data including timed get up (TGU), manual muscle testing, hand grip, pinch dynamometry, as well as IBM functional rating scale (IBMFRS), modified Rankin score, forced vital capacity (FVC), and modified ocular bulbar facial respiratory scale (mOBFRS) were collected on all patients. Descriptive statistics and Pearson's r correlation were performed to analyze the data. Age of the patient did not correlate with any of the outcome measures. Greater severity of IBMFRS scores correlated with longer disease duration as well as greater severity for FVC, strength outcomes, TGU, modified Rankin, and mOBFRS. Additionally, TGU strongly correlated with muscle strength measurements, modified Rankin, and mOBFRS. mOBFRS moderately correlated with IBMFRS, muscle strength, FVC, TGU and modified Rankin score. We demonstrate moderate to strong correlations among the disease severity outcome measures in this study.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Miosite de Corpos de Inclusão Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Miosite de Corpos de Inclusão Idioma: En Ano de publicação: 2022 Tipo de documento: Article